Skip Ribbon Commands
Skip to main content

My child has

Because childhood should be simple ...

Paul W. Bowman, MD
Cook Children's Physician Network

Paul W. Bowman
Specialties:Hematology/Oncology
Education:University of Manitoba, Canada
Residency:University of Manitoba, Canada
Fellowship:St. Jude Children's Research Hospital, Tennessee
Board Certified:Pediatrics and Pediatric Hematology/Oncology

Best doctors in America Super Doctors


Locations:

1500 Cooper St.
Fort Worth, TX 76104
(682) 885-4007
Driving directions
1401 Ambler Ave., Ste. 101
Abilene, TX 79601
(325) 670-3910
Driving directions
701 W. Fifth, Ste. 2106
Odessa, Texas 79764
(432) 570-5693
Driving directions

Publications:

Fernandez, C. A., Smith, C., Yang, W., Mullighan, C. G., Qu, C., Larsen, E., BOWMAN, W. P., Liu, C., Ramsey, L. B., Chang, T., Karol, S. E., Loh, M. L., Raetz, E. A., Winick, N. J., Hunger, S. P., Carroll, W. L., Jeha, S., Pui, C. H., Evans, W. E., Devidas, M., & Relling, M. V. (2015). Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. Blood, 126(1), 69-75.

Karol, S. E., Coustan-Smith, E., Cao, X., Shurtleff, S. A., Raimondi, S. C., Choi, J. K., Ribeiro, R. C., Dahl, G. V., BOWMAN, W. P., Taub, J. W., Degar, B., Leung, W., Downing, J. R., Pui, C. H., Rubnitz, J. E., Campana, D., & Inaba, H. (2015). Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. British Journal of Haematology, 168(1), 94-101.

Kaste, S. C., Pei, D., Cheng, C., Neel, M. D., BOWMAN, W. P., Ribeiro, R. C., Metzger, M. L., Bhojwani, D., Inaba, H., Campbell, P., Rubnitz, J. E., Jeha, S., Sandlund, J. T., Downing, J. R., Relling, M. V., Pui, C. H., & Howard, S. C. (2015). Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(6), 610-615.

Leger, K., Slone, T., Lemler, M., Leonard, D., Cochran, C., BOWMAN, W. P., BASHORE, L. M., & Winick, N. (2015). Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy. Pediatric Blood & Cancer, 62(1), 123-127.

Moriyama, T., Metzger, M. L., Wu, G., Nishii, R., Qian, M., Devidas, M., Yang, W., Cheng, C., Cao, X., Quinn, E., Raimondi, S., Gastier-Foster, J. M., Raetz, E., Larsen, E., Martin, P. L., BOWMAN, W. P., Winick, N., Komada, Y., Wang, S., Edmonson, M., Xu, H., Mardis, E., Fulton, R., Pui, C. H., Mullighan, C., Evans, W. E., Zhang, J., Hunger, S. P., Relling, M. V., Nichols, K. E., Loh, M. L., & Yang, J. J. (2015). Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: A systematic genetic study. The Lancet.Oncology, 16(16), 1659-1666.

Mou, M., WILSON, D. P., Davis, S., Matches, S., Shah, D., LEUNG-PINEDA, V., Suzuki, S., McNeal, C. J., & BOWMAN, W. P. (2015). Universal cholesterol screening of all 9- to 11-year-old children in community-based ambulatory pediatric clinics. Journal of Clinical Lipdology, 9(3), 443.

Mullighan, C. G., Jeha, S., Pei, D., Payne-Turner, D., Coustan-Smith, E., Roberts, K. G., Waanders, E., Choi, J. K., Ma, X., Raimondi, S. C., Fan, Y., Yang, W., Song, G., Yang, J. J., Inaba, H., Downing, J. R., Leung, W. H., BOWMAN, W. P., Relling, M. V., Evans, W. E., Zhang, J., Campana, D., & Pui, C. H. (2015). Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels. Blood, 126(26), 2896-2899.

Pui, C. H., Pei, D., Coustan-Smith, E., Jeha, S., Cheng, C., BOWMAN, W. P., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Inaba, H., Bhojwani, D., Gruber, T. A., Leung, W. H., Downing, J. R., Evans, W. E., Relling, M. V., & Campana, D. (2015). Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: A prospective study. The Lancet.Oncology, 16(4), 465-474.

Shelake, S., Eslin, D., Sutphin, R. M., Sankpal, U. T., Wadwani, A., Kenyon, L. E., Tabor-Simecka, L., BOWMAN, W. P., Vishwanatha, J. K., & Basha, R. (2015). Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation. International Journal of Developmental Neuroscience : The Official Journal of the International Society for Developmental Neuroscience, 46, 92-99.

WILSON, D. P., Davis, S., Matches, S., Shah, D., LEUNG-PINEDA, V., Mou, M., Hamilton, L., McNeal, C. J., & BOWMAN, W. P. (2015). Universal cholesterol screening of children in community-based ambulatory pediatric clinics. Journal of Clinical Lipidology, 9(5S), S88-S92.

Wilson, D. P., Davis, S., Matches, S., Shah, D., LEUNG-PINEDA, V., Mou, M., Hamilton, L., McNeal, C. J., & BOWMAN, W. P. (2015). Universal cholesterol screening of children in community-based ambulatory pediatric clinics. Journal of Clinical Lipidology, 9(5 Suppl), S88-92.

Xu, H., Zhang, H., Yang, W., Yadav, R., Morrison, A. C., Qian, M., Devidas, M., Liu, Y., Perez-Andreu, V., Zhao, X., Gastier-Foster, J. M., Lupo, P. J., Neale, G., Raetz, E., Larsen, E., BOWMAN, W. P., Carroll, W. L., Winick, N., Williams, R., Hansen, T., Holm, J. C., Mardis, E., Fulton, R., Pui, C. H., Zhang, J., Mullighan, C. G., Evans, W. E., Hunger, S. P., Gupta, R., Schmiegelow, K., Loh, M. L., Relling, M. V., & Yang, J. J. (2015). Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nature Communications, 6, 7553.

Basha, R., Sabnis, N., HEYM, K. M., BOWMAN, W. P., & Lacko, A. G. (2014). Targeted nanoparticles for pediatric leukemia therapy. Frontiers in Oncology, 4, 101.

Eslin, D., Sankpal, U. T., Lee, C. M., Sholler, G. S., Sutphin, R. M., BOWMAN, W. P., MURRAY, J. C., & Basha, R. M. (2014). Nifurtimox enhances the therapeutic efficacy of radiation by inducing reactive oxygen species and related pathways: Pre-clinical study in medulloblastoma. Cancer Research, 74(19)

Eslin, D., Sankpal, U. T., Lee, C. M., Sutphin, R. M., BOWMAN, W. P., MURRAY, J. C., & Basha, R. (2014). Tolfenamic acid enhances the therapeutic efficacy of certain chemotherapeutic agents in medulloblastoma cell lines. Cancer Research, 74(19)

Fernandez, C. A., Smith, C., Yang, W., Date, M., Bashford, D., Larsen, E., BOWMAN, W. P., Liu, C., Ramsey, L. B., Chang, T., Turner, V., Loh, M. L., Raetz, E. A., Winick, N. J., Hunger, S. P., Carroll, W. L., Onengut-Gumuscu, S., Chen, W. M., Concannon, P., Rich, S. S., Scheet, P., Jeha, S., Pui, C. H., Evans, W. E., Devidas, M., & Relling, M. V. (2014). HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. Blood, 124(8), 1266-1276.

Gupta, R., Noorudeen, S., GALLIANI, C. A., ALBRITTON, K. H., & BOWMAN, W. P. (2014). Metastatic peritoneal mesothelioma in a 21-year-old female with chronic myelogenous leukemia. Journal of Adolescent and Young Adult Oncology, 3(3), 138-141.

MURRAY, J. C., Sankpal, U. T., Tabor, L., Felini, M., BOWMAN, W. P., & Basha, R. (2014). Small molecule tolfenamic acid inhibits markers of angiogenesis in medulloblastoma cells via targeting specificity protein transcription factors. 46th Congress of the International Society of Paediatric Oncology. Toronto, Ontario CANADA.

MURRAY, J. C., Umesh, R. S., Tabor, L., Felini, M., BOWMAN, W. P., & Basha, R. (2014). Small molecule tolfenamic acid inhibits markers of angiogenesis in medulloblastoma cells via targeting specificity protein transcription factors. 46th Congress of the International Society of Paediatric Oncology (SIOP). Toronto, Ontario Canada.

Pui, C. H., Pei, D., Campana, D., Cheng, C., Sandlund, J. T., BOWMAN, W. P., Hudson, M. M., Ribeiro, R. C., Raimondi, S. C., Jeha, S., Howard, S. C., Bhojwani, D., Inaba, H., Rubnitz, J. E., Metzger, M. L., Gruber, T. A., Coustan-Smith, E., Downing, J. R., Leung, W. H., Relling, M. V., & Evans, W. E. (2014). A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia, 28(12), 2336-2343.

Schultz, K. R., Carroll, A., Heerema, N. A., BOWMAN, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Zheng, H. W., Davies, S. M., Gaynon, P. S., Trigg, M., Rutledge, R., Jorstad, D., Winick, N., Borowitz, M. J., Hunger, S. P., Carroll, W. L., & Camitta, B. (2014). Long-term follow-up of imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia: Children's oncology group study AALL0031. Leukemia, 28(7), 1467-1471.

Schultz, K. R., Devidas, M., BOWMAN, W. P., Aledo, A., Slayton, W. B., Sather, H., Zheng, H. W., Davies, S. M., Gaynon, P. S., Trigg, M., Rutledge, R., Jorstad, D., Carroll, A. J., Heerema, N., Winick, N., Borowitz, M. J., Hunger, S. P., Carroll, W. L., Camitta, B., & Children's Oncology Group. (2014). Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: Results from children's oncology group study AALL0031. Leukemia, 28(4), 964-967.

Karol, S. E., Coustan-Smith, E., Cao, X., Shurtleff, S. A., Raimondi, S. C., Choi, J. K., Ribeiro, R. C., Dahl, G. V., BOWMAN, W. P., Taub, J. W., Degar, B., Leung, W., Downing, J. R., Pui, C. H., Rubnitz, J. E., Campana, D., & Inaba, H. (2013). Prognostic factors for children with acute myeloid leukemia who achieve minimal residual disease-negative status after induction therapy. Blood, 122(21)

Loh, M. L., Zhang, J., Harvey, R. C., Roberts, K., Payne-Turner, D., Kang, H., Wu, G., Chen, X., Becksfort, J., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I. M., Wood, B., Borowitz, M. J., Devidas, M., Gerhard, D. S., BOWMAN, W. P., Larsen, E., Winick, N., Raetz, E., Smith, M., Downing, J. R., Willman, C. L., Mullighan, C. G., & Hunger, S. P. (2013). Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: A report from the children's oncology group TARGET project. Blood, 121(3), 485-488.

O'Hear, C., Inaba, H., Pounds, S., Shi, L., Dahl, G., BOWMAN, W. P., Taub, J. W., Pui, C. H., Ribeiro, R. C., Coustan-Smith, E., Campana, D., & Rubnitz, J. E. (2013). Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia. Cancer, 119(22), 4036-4043.

Perez-Andreu, V., Roberts, K. G., Harvey, R. C., Yang, W., Cheng, C., Pei, D., Xu, H., Gastier-Foster, J., Shuyu, E., Lim, J. Y. -., Chen, I. -., Fan, Y., Devidas, M., Borowitz, M. J., Smith, C., Neale, G., Burchard, E. G., Torgerson, D. G., Klussmann, F. A., Villagran, C. R. N., Winick, N. J., Camitta, B. M., Raetz, E., Wood, B., Yue, F., Carroll, W. L., Larsen, E., BOWMAN, W. P., Loh, M. L., Dean, M., Bhojwani, D., Pui, C. H., Evans, W. E., Relling, M. V., Hunger, S. P., Willman, C. L., Mullighan, C. G., & Yang, J. J. (2013). Inherited GATA3 variants are associated with ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nature Genetics, 45(12), 1494-1498. 

Xu, H., Yang, W., Perez-Andreu, V., Devidas, M., Fan, Y., Cheng, C., Pei, D., Scheet, P., Burchard, E. G., Eng, C., Huntsman, S., Torgerson, D. G., Dean, M., Winick, N. J., Martin, P. L., Camitta, B. M., BOWMAN, W. P., Willman, C. L., Carroll, W. L., Mullighan, C. G., Bhojwani, D., Hunger, S. P., Pui, C. H., Evans, W. E., Relling, M. V., Loh, M. L., & Yang, J. J. (2013). Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. Journal of the National Cancer Institute, 105(10), 733-742.

Bhojwani, D., Pei, D., Sandlund, J. T., Jeha, S., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Shurtleff, S., Onciu, M., Cheng, C., Coustan-Smith, E., BOWMAN, W. P., Howard, S. C., Metzger, M. L., Inaba, H., Leung, W., Evans, W. E., Campana, D., Relling, M. V., & Pui, C. H. (2012). ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: Improved outcome with contemporary therapy. Leukemia, 26(2), 265-270.

CABALLERO, R., POOL, C., L., WOLF, R. M., HEYM, K., & BOWMAN, W. P. (2012). ECMO support fo the oncologic and/or immune-suppressed patient. Paper presented at the 24th Annual ELSO (Extracorporial Life Support Organization) Conference, Philadelphia, PA.

Inaba, H., Coustan-Smith, E., Cao, X., Pounds, S. B., Shurtleff, S. A., Wang, K. Y., Raimondi, S. C., Onciu, M., Jacobsen, J., Ribeiro, R. C., Dahl, G. V., BOWMAN, W. P., Taub, J. W., Degar, B., Leung, W., Downing, J. R., Pui, C. H., Rubnitz, J. E., & Campana, D. (2012). Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 30(29), 3625-3632.

Inaba, H., Surprise, H. C., Pounds, S., Cao, X., Howard, S. C., Ringwald-Smith, K., Buaboonnam, J., Dahl, G., BOWMAN, W. P., Taub, J. W., Campana, D., Pui, C. H., Ribeiro, R. C., & Rubnitz, J. E. (2012). Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer, 118(23), 5989-5996.

Rubnitz, J. E., Pounds, S., Cao, X., Jenkins, L., Dahl, G., BOWMAN, W. P., Taub, J. W., Pui, C. H., Ribeiro, R. C., Campana, D., & Inaba, H. (2012). Treatment outcome in older patients with childhood acute myeloid leukemia. Cancer, 118(24), 6253-6259.

Yang, J. J., Cheng, C., Devidas, M., Cao, X., Campana, D., Yang, W., Fan, Y., Neale, G., Cox, N., Scheet, P., Borowitz, M. J., Winick, N. J., Martin, P. L., BOWMAN, W. P., Camitta, B., Reaman, G. H., Carroll, W. L., Willman, C. L., Hunger, S. P., Evans, W. E., Pui, C., Loh, M., & Relling, M. V. (2012). Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood, 120(20), 4197-4204.

Yang, J. J., Cheng, C., Meenakshi, D., Cao, X., Campana, D., Yang, W., Fan, Y., Neale, G. A. M., Cox, N., Scheet, P., Borowitz, M. J., Winick, N., Martin, P. L., BOWMAN, W. P., Camitta, B., Reaman, G., Carroll, W. L., Willman, C. L., Hunger, S. P., Evans, W. E., Pui, C. H., Loh, M. L., & Relling, M. V. (2012). Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood, 120(21), 878.

Yang, J. J., E, S., Shen, S., Bhojwani, D., Kang, H., Ma, Y., Chen, J., Tang, J. Y., Seibel, N. L., Xu, H., Cheng, J., Ramsey, L. B., Crews, K., BOWMAN, W. P., Borowitz, M. J., Carroll, W. L., Willman, C. L., Jeha, S., Pui, C. H., Hunger, S. P., Relling, M. V., & Evans, W. E. (2012). PDE4B modulates glucocorticoid sensitivity in childhood acute lymphoblastic leukemia. Blood, 120(21), 530.

BOWMAN, W. P., Larsen, E. L., Devidas, M., Linda, S. B., Blach, L., Carroll, A. J., Carroll, W. L., Pullen, D. J., Shuster, J., Willman, C. L., Winick, N., Camitta, B. M., Hunger, S. P., & Borowitz, M. J. (2011). Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of children's oncology group trial P9906. Pediatric Blood & Cancer, 57(4), 569-577.

Kawedia, J. D., Liu, C., Pei, D., Cheng, C., Fernandez, C. A., Howard, S. C., Campana, D., Panetta, J. C., BOWMAN, W. P., Evans, W. E., Pui, C. H., & Relling, M. V. (2011). Systemic exposure to dexamethasone and asparaginase affects risk of relapse in children with acute lymphoblastic leukemia. Paper presented at the 53rd Annual Meeting of the American Society of Hematology, ASH 2011, San Diego, CA. , 118(21)

Liu, C., Kawedia, J. D., Cheng, C., Pei, D., Fernandez, C. A., Cai, X., Crews, K., Kaste, S., Panetta, J. C., BOWMAN, W. P., Jeha, S., Sandlund, J., Evans, W. E., Pui, C. H., & Relling, M. V. (2011). Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Blood, 118(21)

Bhojwani, D., Pei, D., Sandlund, J., Jeha, S., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Shurtleff, S., Onciu, M., Cheng, C., Coustan-Smith, E., BOWMAN, W. P., Howard, S. C., Metzger, M. L., Inaba, H., Leung, W. H., Evans, W. E., Campana, D., Relling, M. V., & Pui, C. H. (2010). Excellent outcome for ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL) with contemporary therapy. Blood, 116(21), 220.

Daves, M. H., Hunger, S., Linda, S. B., BOWMAN, W. P., Seibel, N. L., Sung, L., & Devidas, M. (2010). Longer time to the start of continuation therapy is associated with improved survival in high risk pediatric acute lymphoblastic leukemia (ALL): A report from the children's oncology group (COG). Blood, 116(21)

Jeha, S., Pei, D., Campana, D., BOWMAN, W. P., Sandlund, J., Kaste, S., Ribeiro, R. C., Rubnitz, J. E., Coustan-Smith, E., Cheng, C., Metzger, M. L., Bhojwani, D., Inaba, H., Raimondi, S. C., Onciu, M., Howard, S. C., Leung, W. H., Downing, J. R., Evans, W. E., Relling, M., & Pui, C. H. (2010). Improved prognosis for older adolescents with acute lymphoblastic leukemia. Blood, 116(21) 

Mikkelsen, T. S., Sparreboom, A., Cheng, C., Zhou, Y., Boyett, J. M., Raimondi, S. C., Panetta, J. C., BOWMAN, W. P., Pui, C. H., Relling, M. V., & Evans, W. E. (2010). Shortening the infusion time of high-dose methotrexate reduces the accumulation of methotrexate polyglutamates in acute lymphoblastic leukemia cells: Results from the st jude total XV study. Pediatric Blood and Cancer, 55(5), 803.

MURRAY, J. C., ROBERTS, R. A., BOWMAN, W. P., & BASHORE, L. M. (2010). Infant myeloid sarcoma followed by multiple spinal cord plexiform neurofibromas in adolescence: Variable clinical expressivity and the leukemogenic potential of neurofibromatosis type 1 (NF1). Children's Tumor Foundation 2010 NF (Neurofibromatosis) Conference, Baltimore, MD.

Carroll, A. J., Heerema, N. A., Devidas, M., BOWMAN, W. P., Wang, C., Trigg, M., Camitta, B., Gaynon, P. S., Winick, N. J., Hunger, S. P., Carroll, W. L., & Schultz, K. R. (2009). Secondary chromosomal abnormalities appear to be less prognostic for children with philadelphia chromosome positive (ph+) acute lymphoblastic leukemia (ALL) treated with intensified imatinib and chemotherapy: Results of the children's oncology group (COG) study AALL0031. Blood, 114(22) 

Rubnitz, J., Inaba, H., Dahl, G., BOWMAN, W. P., Taub, J., Pui, C. H., Pounds, S., Lacayo, N. J., Cao, X., Ribeiro, R. C., Meshinchi, S., Degar, B., Airewele, G., Onciu, M., Coustan-Smith, E., & Campana, D. (2009). Minimal residual disease-directed therapy for childhood acute myeloid leukemia: Results of the AML02 multicenter trial. Blood, 114(22) 

Adkins, L., & BOWMAN, W. P. (2008). Acute lymphocytic leukemia in relapse: A retrospective analysis of 25 years' experience at cook children's medical center. 21st Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO). Cincinnati, OH.

Borowitz, M. J., Devidas, M., Hunger, S. P., BOWMAN, W. P., Carroll, A. J., Carroll, W. L., Linda, S., Martin, P. L., Pullen, D. J., Viswanatha, D., Willman, C. L., Winick, N., Camitta, B. M., & Children's Oncology, G. (2008). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A children's oncology group study. Blood, 111(12), 5477-5485.

Davies, S. M., Borowitz, M. J., Rosner, G. L., Ritz, K., Devidas, M., Winick, N., Martin, P. L., BOWMAN, W. P., Elliott, J., Willman, C., Das, S., Cook, E. H., & Relling, M. V. (2008). Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: A report from the children's oncology group. Blood, 111(6), 2984-2990.

Gaynon, P. S., Camitta, B. C., Matloub, Y., Martin, P. L., Winick, N., Seibel, N. L., BOWMAN, W. P., Sather, H. N., Devidas, M., Hunger, S., & Carroll, W. L. (2007). Outcomes for B-precursor patients in legacy children's cancer group (CCG) and pediatric oncology group (POG) studies in childhood acute lymphoblastic leukemia (ALL): A children's oncology group (COG) report. 49th ASH (American Society of Hematology) Annual Meeting and Exposition, Atlanta, GA. , 110(11) 847.

Harvey, R. C., Davidson, G. S., Wang, X., Dobbin, K. K., Bedrick, E. J., Wilson, C. S., Atlas, S. R., Kang, H., Chen, I., Hunger, S. P., Devidas, M., Carroll, W. L., BOWMAN, W. P., Camitta, B., Reaman, G., & Willman, C. L. (2007). Expression profiling identifies novel genetic subgroups with distinct clinical features and outcome in high-risk pediatric precursor B acute lymphoblastic leukemia (B-ALL). A children's oncology group study. 49th ASH (American Society of Hematology) Annual Meeting and Exposition, Atlanta, GA. , 110(11) 1430.

Borowitz, M. J., Pullen, D. J., Winick, N., Martin, P. L., BOWMAN, W. P., & Camitta, B. (2005). Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group. Cytometry Part B, Clinical Cytometry, 68(1), 18-24.

Hutchison, R. E., Finch, C., Kepner, J., Fuller, C., BOWMAN, W. P., Link, M., Schwenn, M., Laver, J., Desai, S., Barrett, D., & Murphy, S. B. (2000). Burkitt lymphoma is immunophenotypically different from burkitt-like lymphoma in young persons. Annals of Oncology, 11(SUPPL. 1), S35; S38.

Bernstein, M. L., Abshire, T. C., Pollock, B. H., Devine, S., Toledano, S., Steuber, C. P., BOWMAN, W. P., & Buchanan, G. R. (1997-Feb). Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: A pediatric oncology group study. Journal of Pediatric Hematology/Oncology, 19(1), 68-72.

Frankel, L. S., Ochs, J., Shuster, J. J., Dubowy, R., BOWMAN, W. P., Hockenberry-Eaton, M., Borowitz, M., Carroll, A. J., Steuber, C. P., & Pullen, D. J. (1997-Feb). Therapeutic trial for infant acute lymphoblastic leukemia: The pediatric oncology group experience (POG 8493). Journal of Pediatric Hematology/Oncology, 19(1), 35-42.

Bernstein, M. L., Abshire, T. C., Pollock, B. H., Devine, S., Toledano, S., Steuber, C. P., BOWMAN, W. P., & Buchanan, G. R. (1997). Idarubicin and cytosine arabinoside reinduction therapy for children with multiple recurrent or refractory acute lymphoblastic leukemia: A pediatric oncology group study. Journal of Pediatric Hematology/Oncology, 19(1), 68-72.

Brecher, M. L., Schwenn, M. R., Coppes, M. J., BOWMAN, W. P., Link, M. P., Berard, C. W., Shuster, J. J., & Murphy, S. B. (1997). Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): A randomized trial of the pediatric oncology group. Medical & Pediatric Oncology, 29(6), 526-533.

Farrow, A. C., Buchanan, G. R., Zwiener, R. J., BOWMAN, W. P., & Winick, N. J. (1997). Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 15(4), 1560-1566.

Frankel, L. S., Ochs, J., Shuster, J. J., Dubowy, R., BOWMAN, W. P., Hockenberry-Eaton, M., Borowitz, M., Carroll, A. J., Steuber, C. P., & Pullen, D. J. (1997). Therapeutic trial for infant acute lymphoblastic leukemia: The pediatric oncology group experience (POG 8493). Journal of Pediatric Hematology/Oncology, 19(1), 35-42.

BOWMAN, W. P., Shuster, J. J., Cook, B., GRIFFIN, T. C., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C., & Murphy, S. (1996). Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A pediatric oncology group study. Journal of Clinical Oncology, 14(4), 1252-1261.

GRIFFIN, T. C., BOWMAN, W. P., Winick, N. J., & Buchanan, G. R. (1994). Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: Further experience with total therapy B. Medical & Pediatric Oncology, 23(5), 393-399.

Felix, C. A., Winick, N. J., Negrini, M., BOWMAN, W. P., Croce, C. M., & Lange, B. J. (1993). Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer Research, 53(13), 2954-2956.

Douglass, E. C., Rowe, S. T., Valentine, M., Parham, D. M., Berkow, R., BOWMAN, W. P., & Maurer, H. M. (1991). Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes, Chromosomes & Cancer, 3(6), 480-482.

Brown, R. E., Alade, S. L., Wu, M. C., Wu, F. M., & BOWMAN, W. P. (1989). Lipoperoxidation and T-cell leukemia of childhood. effects of indomethacin. Cancer, 64(10), 2090-2095.

Alade, S. L., Brown, R. E., & BOWMAN, W. P. (1988). Serum vitamin A status in acute lymphocytic leukemia of childhood. Annals of Clinical & Laboratory Science, 18(2), 155-161.

Brown, R. E., BOWMAN, W. P., D'Cruz, C. A., Pick, T. E., & Champion, J. E. (1987). Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. reversal with VP-16 and indomethacin. Cancer, 60(10), 2388-2393.

Evans, W. E., Abromowitch, M., Crom, W. R., Relling, M. V., BOWMAN, W. P., Pui, C. H., Ochs, J., & Dodge, R. (1987). Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia. NCI Monographs, (5), 81-85.

Evans, W. E., Crom, W. R., Abromowitch, M., Dodge, R., Look, A. T., BOWMAN, W. P., George, S. L., & Pui, C. H. (1986). Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. identification of a relation between concentration and effect. New England Journal of Medicine, 314(8), 471-477.

Abromowitch, M., BOWMAN, W. P., Ochs, J., & Rivera, G. (1985). Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia. Journal of Clinical Oncology, 3(6), 789-792.

BOWMAN, W. P. (1985). Advances in the management of childhood leukemia. Texas Medicine, 81(3), 39-44.

BOWMAN, W. P., Aur, R. J., Hustu, H. O., & Rivera, G. (1984). Isolated testicular relapse in acute lymphocytic leukemia of childhood: Categories and influence on survival. Journal of Clinical Oncology, 2(8), 924-929.

Evans, W. E., Crom, W. R., Stewart, C. F., BOWMAN, W. P., Chen, C. H., Abromowitch, M., & Simone, J. V. (1984). Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet, 1(8373), 359-362.

BOWMAN, W. P., Ochs, J., Pui, C. H., Kalwinsky, D. K., Abromowitch, M., & Aur, R. J. (1983). New directions of St. Jude total-therapy protocols: Study X for standard-risk childhood acute lymphoblastic leukemia. Leukemia Research, 7, 203-211.

Buchanan, G. R., BOWMAN, W. P., & Smith, S. J. (1983). Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia. Journal of Pediatrics, 103(6), 921-923.

Evans, W. E., Hutson, P. R., Stewart, C. F., Cairnes, D. A., BOWMAN, W. P., Rivera, G., & Crom, W. R. (1983). Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. Clinical Pharmacology & Therapeutics, 33(3), 301-307.

Bernard, A., Murphy, S. B., Melvin, S., BOWMAN, W. P., Caillaud, J., Lemerle, J., & Boumsell, L. (1982). Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood, 59(3), 549-554.

Dow, L. W., Chang, L. J., Tsiatis, A. A., Melvin, S. L., & BOWMAN, W. P. (1982). Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukemia. Blood, 59(6), 1197-1202.

Evans, W. E., Stewart, C. F., Hutson, P. R., Cairnes, D. A., BOWMAN, W. P., Yee, G. C., & Crom, W. R. (1982). Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia. Drug Intelligence & Clinical Pharmacy, 16(11), 839-842.

Ali, S. K., BOWMAN, W. P., & Aur, R. J. (1981). Increased radiation sensitivity of fibroblasts in ataxia telangiectasia with acute lymphocytic leukemia. American Journal of Diseases of Children, 135(12), 1142-1143.

BOWMAN, W. P. (1981). Childhood acute lymphocytic leukemia: Progress and problems in treatment. Canadian Medical Association Journal, 124(2), 129-142. 

BOWMAN, W. P., & Mauer, A. (1981). The role of cell markers in the management of leukemia. Progress in Hematology, 12, 165-185.

BOWMAN, W. P., Melvin, S. L., Aur, R. J., & Mauer, A. M. (1981). A clinical perspective on cell markers in acute lymphocytic leukemia. Cancer Research, 41(11 Pt 2), 4794-4801.

Brodeur, G. M., Williams, D. L., Look, A. T., BOWMAN, W. P., & Kalwinsky, D. K. (1981). Near-haploid acute lymphoblastic leukemia: A unique subgroup with a poor prognosis? Blood, 58(1), 14-19.

BOWMAN, W. P., Melvin, S., & Mauer, A. M. (1980). Cell markers in lymphomas and leukemias. Advances in Internal Medicine, 25, 391-425.

Aur, R. J., Hustu, H. O., Verzosa, M., Johnson, W. W., Simone, J., Rivera, G., Dahl, G. V., & BOWMAN, W. P. (1979). ["Total therapy" for localized and regional malignant non-hodgkin's lymphoma of children. A second look (author's transl)]. ["Terapeutica total" en los linfomas malignos no hodgkinianos de la infancia, localizados y regionales. Segunda estimacion.] Sangre, 24(6), 1031-1042.

CABALLERO, R., Pool, C. L., Wolf, R. M., HEYM, K., & BOWMAN, W. P.ECMO support for the oncologic and/or immune-suppressed patient.

Rocket Fuel